Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201112110 Principal Investigator: Westervelt, Peter
Title: A Phase 3, Multicenter, Randomized Study to Evaluate the Substitution of Marqibo® (Vincristine Sulfate Liposomes Injection, VSLI) for Standard Vincristine Sulfate Injection (VSI) in the Induction, Intensification, and Maintenance Phases of Combination Chemotherapy in the Treatment of Subjects >/= 60 Years Old with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Phase: III Disease Site: Lymphoid Leukemia
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purposes of this research study are:

To compare the overall survival in patients 60-years of age and older who are newly diagnosed with ALL and treated with a combination chemotherapy which includes either VSI or Marqibo

To compare the side effects between the 2 chemotherapy treatment groups
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)